PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 16 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,737,000 | – | 2,000,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 37,825,000 | $25,876,000 | 3.78% |
| PenderFund Capital Management Ltd. | 13,060,000 | $9,300,000 | 3.13% |
| Telemetry Investments, L.L.C. | 1,500,000 | $1,084,000 | 3.13% |
| Context Capital Management, LLC | 1,600,000 | $1,157,000 | 0.66% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,750,000 | $20,019,000,000 | 0.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,750,000 | $2,712,000 | 0.08% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,182,000 | $5,264,000 | 0.04% |
| AQR Arbitrage LLC | 3,050,000 | $2,236,000 | 0.03% |
| Teton Advisors, Inc. | 400,000 | $280,000 | 0.03% |
| GABELLI FUNDS LLC | 3,750,000 | $2,629,000 | 0.02% |